29 May 2026
: Case report
[In Press] Recurrent Ischemic Strokes Caused by HSV-2–Associated Cerebral Vasculitis in Antisynthetase Syndrome
Rare disease
Christian M. RäzDOI: 10.12659/AJCR.952736
Am J Case Rep In Press; DOI: 10.12659/AJCR.952736
Available online: 2026-05-29, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Antisynthetase syndrome is a rare autoimmune disease characterized by anti-aminoacyl-tRNA synthetase autoantibodies and clinical features including interstitial lung disease, myositis, and arthritis, requiring immunosuppressive treatment. We report a case of a patient with antisynthetase syndrome who developed a severe herpes simplex virus 2 (HSV-2) encephalitis with vasculitis and recurrent strokes.
CASE REPORT
A 76-year-old woman with antisynthetase syndrome on rituximab, mycophenolate mofetil, and prednisone presented with progressive headache, confusion, and gait disturbance. MRI demonstrated bilateral temporal cortical hyperintensities consistent with encephalitis, as well as acute ischemic lesions in the left middle cerebral artery territory. Cerebrospinal fluid analysis showed HSV-2 DNA. Despite intravenous acyclovir, the patient developed aphasia and left-sided neglect. Repeated MRI revealed middle cerebral artery branch occlusion and concentric vessel wall enhancement, consistent with central nervous system vasculitis and multiple acute infarcts. On further follow-up, serial cerebrospinal fluid testing showed delayed viral clearance over 7 weeks. Management included acyclovir and discontinuation of rituximab to allow immune system recovery. Empiric antiplatelet therapy and antiepileptic therapy were added because of suspected intermittent epileptic seizures, with epileptogenic potentials identified on electroencephalogram. After 9 weeks of treatment and rehabilitation, the patient reached partial neurological recovery. Despite residual mild left gaze palsy and fatigue, she regained full functional independence in all activities of daily living.
CONCLUSIONS
To the best of our knowledge, this is the first reported case of a patient with antisynthetase syndrome who developed HSV-2 encephalitis complicated by vasculitis and recurrent ischemic strokes. Immunosuppressive treatment may have contributed to delayed HSV-2 clearance, necessitating prolonged acyclovir therapy.
Keywords: Case Reports; Cerebral Vasculitis; Herpes Simplex Virus Encephalitis; Neurology
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






